TYK MEDICINES-B (02410) has been awarded the "Drug Production License" by the Zhejiang Provincial Drug Administration.

19:27 23/01/2026

Tongyuan Kang Pharmaceutical-B (02410) announced that the company has been granted the "Drug Production License" by the Zhejiang Provincial Drug Administration. Obtaining the drug production license this time is expected to have a positive long-term impact on the company's expansion of production capacity and market expansion, laying the foundation for future commercial production. It is hoped that better treatment options will be soon provided to patients to meet the urgent medical needs in cancer treatment.

TYK MEDICINES-B(02410) announced that the company has been awarded the "Drug Manufacturing License" by the Zhejiang Provincial Drug Administration. This drug manufacturing license is expected to have a long-term positive impact on the company's expansion of production capacity and market expansion, laying a foundation for future commercial production. It is hoped that better treatment options will be provided to patients sooner in order to meet the urgent medical needs in cancer treatment.

OKURA HOLDINGS (01655) is planning to discount approximately 15.88% of the maximum 84,980,400 shares for a net raise of approximately HK$10.38 million.

UJU HOLDING (01948): No longer providing one-stop service, only charging advertising operation service fees to major customers.

GEMILANG INTL (06163) announces annual performance Company owners' share of losses amounted to $430,000, a year-on-year decrease of 58.13%.

OKURA HOLDINGS (01655) is planning to discount approximately 15.88% of the maximum 84,980,400 shares for a net raise of approximately HK$10.38 million.

UJU HOLDING (01948): No longer providing one-stop service, only charging advertising operation service fees to major customers.

GEMILANG INTL (06163) announces annual performance Company owners' share of losses amounted to $430,000, a year-on-year decrease of 58.13%.